Other
ESS
0
Pipeline Programs↗
56
Active Trials↗
117
Companies Involved↗
ESS is an early-stage landscape with 0 programs across 117 companies. The most active players are AstraZeneca, GSK, Pfizer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
770
clinical trials
Completed456 · 59%
Unknown status68 · 9%
No longer available62 · 8%
Terminated46 · 6%
Available40 · 5%
Recruiting33 · 4%
Other65 · 8%
Clinical Trials
Trial Activity
770 trials
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
Recruiting·—·N/A·NCT06338865·294 enrolled
Assessment of Synaptic Density in MS
Recruiting·—·Phase 1·NCT04634994·30 enrolled
Graded Insulin Suppression Test P&F
Recruiting·—·Phase 1·NCT06592261·15 enrolled
Page 1 of 52
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)